Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q2 2012 · —
Revenue$5.31B$5.31B−44.8% vs Q2 2011 Net Income$1.73B$1.73B−11.2% vs Q2 2011 EPS Diluted$1.08$1.08−12.2% vs Q2 2011 Gross Profit$2,748,000,000−52.2% Operating Income$564,190,000−68.2% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
$2,066,829,000
−17.4%
Free Cash Flowderived$1,641,713,000−22.9% Margins · derivedGross margin51.7%−8.0 pt vs Q2 2011
Operating margin10.6%−7.8 pt vs Q2 2011
Net margin32.5%+12.3 pt vs Q2 2011